Diabetes complications

Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease

Cardiovasc DiabetolPublished Diagnostic accuracy study

Authors' conclusion

Our findings suggest that it is possible to achieve high sensitivity and accuracy using an algorithm with VLF and TP parameters analyzed in series.

Study context

Population
Patients with T2D and diabetic kidney disease (DKD) with severely increased albuminuria
Participants
48 patients
Comparison
Heart Rate Variability (HRV) tests vs cardiovascular autonomic reflex tests (CARTs) for diagnosing Cardiovascular Autonomic Neuropathy (CAN)
Outcome
Sensitivity and specificity of HRV tests to diagnose CAN
Methodological detailscross-sectional
  • Cross-sectional

Performance

As reported in the abstract

Diagnostic performance of HRV tests for CAN
Test or modelCut-offSensitivityF1 ScoreSpecificityAccuracy
VLF< 1,117 ms297%90%
LF< 152.5 ms275%
TP< 1,891 ms292%90%85%
SDNN< 46.5 ms

Cut-off

VLF< 1,117 ms2
LF< 152.5 ms2
TP< 1,891 ms2
SDNN< 46.5 ms

Sensitivity

VLF97%
LF— not stated in the abstract
TP92%
SDNN— not stated in the abstract

F1 Score

VLF90%
LF— not stated in the abstract
TP90%
SDNN— not stated in the abstract

Specificity

VLF— not stated in the abstract
LF75%
TP— not stated in the abstract
SDNN— not stated in the abstract

Accuracy

VLF— not stated in the abstract
LF— not stated in the abstract
TP85%
SDNN— not stated in the abstract
Serial algorithm (VLF first, then TP): sensitivity
97%
Serial algorithm (VLF first, then TP): accuracy
90%
Serial algorithm: reduction in need to perform CARTs
90%

Further findings

Prevalence of CAN by CARTs

CAN confirmed
75% (36/48)

HRV values with vs without CAN

VLF: 212 vs 522 ms2
P = 0.024
LF: 57 vs 332 ms2
P = 0.025
TP: 359.5 vs 2733 ms2
P = 0.007
SDNN: 20 vs 48 ms
P = 0.012
  • With CAN vs without CAN, respectively

Original publication

Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease. Cardiovasc Diabetol. Published 28 March 2025. doi:10.1186/s12933-025-02666-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.